The timing almost writes the pitch deck itself.
Just as European hospitals face their strictest cybersecurity mandates in years—and as U.S. healthcare data breaches hit record levels in 2025—a London-based startup called SecurITe has secured what it describes as a double-digit million-euro seed round to fund an artificial intelligence platform designed specifically for clinical networks. The company, founded in 2024, announced the financing on May 27, 2026, alongside the commercial debut of agentis360, its so-called "agentic AI" security system.
SecurITe isn't disclosing the investor behind the round, saying only that it partnered with an independent European financial partner. Nor will it share the precise euro figure or its post-money valuation. That opacity isn't unusual for European seed deals, though it leaves open questions about how much runway the startup has bought itself in what's become a brutally competitive corner of the cybersecurity market.
What the company will talk about: the 30-plus enterprise customers it claims to have signed before the public launch, many of them hospitals and critical infrastructure operators. Those contracts, disclosed through SecurITe's partnership with x-tention group—a healthcare IT firm with more than 1,000 customers across Europe—suggest the platform found some early traction even before its formal unveiling at DMEA 2026, the digital health conference in Berlin that drew 22,000 attendees in April.
The Healthcare Security Problem Gets Worse
If SecurITe's founders needed a market tailwind, they got one. Last year was the worst on record for large healthcare data breaches in the United States: 772 incidents affecting nearly 140 million individuals, according to a HIPAA Journal analysis of federal breach portal data published in June. European regulators, meanwhile, have tightened cybersecurity requirements for hospitals and other critical infrastructure under frameworks like the NIS2 directive, raising the compliance stakes for health systems already struggling with skeletal IT budgets.
CEO Manuel Nedbal and CTO Sumanth Gangashanaiah—both alumni of Netskope, McAfee, and ShieldX, with Nedbal also bringing experience from Google, Fortinet, and Intel—argue that the standard enterprise security toolkit doesn't translate well to clinical environments. Medical devices still run outdated operating systems. Networks mix legacy equipment with cloud-connected diagnostics tools. And hospital IT teams, perpetually understaffed, can't afford to babysit alerts around the clock.
SecurITe's answer is what it calls an "agentic-native" approach: coordinated AI agents that supposedly understand healthcare-specific protocols, detect anomalous behavior across devices and networks, and execute responses autonomously. The idea, in theory, is to move beyond passive monitoring toward systems that can act without waiting for a human analyst to triage every ping.
Whether that vision holds up under real-world clinical complexity remains to be seen. The platform is still new, and the company's customer count—while respectable for a seed-stage startup—hardly represents mass adoption.
A Crowded Field
SecurITe is hardly alone in chasing the healthcare cybersecurity opportunity. Claroty, which acquired medical device security specialist Medigate and reportedly raised $150 million in January, has built a sizable presence in hospital networks. So have Armis, Ordr, and Cynerio, all of which offer some version of IoT and medical device visibility.
The wrinkle SecurITe is betting on: that visibility alone isn't enough. Hospitals don't just need dashboards showing which devices are connected; they need systems capable of making split-second decisions in a clinical context where downtime can have life-or-death consequences. It's a reasonable thesis, though executing on it means navigating the risk-averse culture of healthcare IT procurement and the technical minefield of integrating with proprietary medical systems.
The startup operates across three offices—London, Austria, and Santa Clara—a geographic spread that hints at ambitions beyond Europe. The company says it plans to funnel the new capital into commercial expansion across Europe, the UK, and the United States, while building out its go-to-market partnerships and engineering team.
The Unanswered Questions
For all the momentum SecurITe appears to be building, gaps in the public narrative persist. The company won't name its lead investor or detail the round's structure beyond "double-digit million euros"—a range that could mean €10 million or something approaching €100 million, a rather significant difference in implied traction and runway.
There's also the matter of validation. Thirty customers sounds promising until you consider how many hospital systems exist across Europe and North America, and how slowly healthcare organizations tend to adopt new security infrastructure. Early pilots don't always translate into scaled deployments, particularly when a platform's value proposition hinges on autonomous decision-making in environments where liability concerns loom large.
Still, the broader trend is hard to ignore. Healthcare has become one of the most targeted sectors for cyberattacks, and legacy defenses built for corporate IT environments keep failing in clinical settings. If SecurITe can prove its AI agents deliver meaningful risk reduction without adding operational friction, it may find a receptive audience among CISOs who've run out of other options.
Or perhaps the real test will be whether hospitals trust machines to make security calls in networks where a false positive could mean a ventilator goes offline. That's not a technical challenge. It's a human one.
